Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with high androgen levels may have more severe COVID-19 symptoms.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

New compounds may soon be tested to treat excessive hair growth in women.

DHT deficiency can disrupt cell connections in rat testes, possibly affecting fertility.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Ganoderma lucidum may help treat enlarged prostate in rats.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Modified stem cells from umbilical cord blood can make hair grow faster.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

DA-9401 helps protect rat testis from finasteride damage.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.